Olmesartan vs Losartan for Hypertension

Special Populations and Considerations

• The American College of Cardiology and other guideline societies recommend losartan for reducing stroke risk in hypertensive patients with left ventricular hypertrophy, demonstrating a 25% stroke reduction compared to atenolol in the LIFE trial, with optimal dosing for cardiovascular protection requiring 100-150 mg daily 1, 2
• The American Diabetes Association and the National Kidney Foundation recommend both olmesartan and losartan as first-line agents for diabetic kidney disease, with dosing ranges of 20-40mg daily for olmesartan and 25-100mg daily for losartan 3

Dosing Strategy

• The European Society of Cardiology recommends upfront combination therapy with single-pill combinations for most hypertensive patients, combining an ARB with either a calcium channel blocker or thiazide diuretic 4
• The American Heart Association recommends losartan: start 50mg once daily, titrate to 100mg daily (in 1-2 divided doses) for optimal effect, and olmesartan: start 20mg once daily, titrate to 40mg if needed 3

Safety Profile

• The American College of Cardiology and other guideline societies recommend monitoring renal function and potassium at baseline and 2-4 weeks after initiation of olmesartan or losartan, due to the risk of hyperkalemia, particularly in chronic kidney disease 1
• The European Society of Cardiology and other guideline societies recommend never combining either agent with ACE inhibitors or direct renin inhibitors due to increased adverse events without additional benefit 4, 1, 2